Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) reported Q4 EPS of ($0.07), $0.02 worse than the analyst estimate of ($0.05).

For earnings history and earnings-related data on Rani Therapeutics Holdings, Inc. (RANI) click here.